| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Akira Kugaya, Gerard Sanacor. Beyond monoamines: glutamatergic function in mood disorders. CNS spectrums. vol 10. issue 10. 2006-03-08. PMID:16400244. |
the monoamine theory has implicated abnormalities in serotonin and norepinephrine in the pathophysiology of major depression and bipolar illness and contributed greatly to our understanding of mood disorders and their treatment. |
2006-03-08 |
2023-08-12 |
human |
| Michelle Landry, Mark Frasier, Zhuo Chen, Louis D Van De Kar, Yahong Zhang, Francisca Garcia, George Battagli. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin. Synapse (New York, N.Y.). vol 58. issue 2. 2006-03-06. PMID:16088947. |
various childhood mood disorders are being treated with serotonin selective reuptake inhibitors (ssris) such as fluoxetine (prozac(r)), yet limited data are available on their effects on serotonergic systems prior to maturation. |
2006-03-06 |
2023-08-12 |
rat |
| Boldizsár Czéh, Mária Simo. [Neuroplasticity and depression]. Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata. vol 20. issue 1. 2006-02-23. PMID:16389729. |
early hypotheses on the pathophysiology of mood disorders were based on aberrant intrasynaptic concentrations of the neurotransmitters serotonin and norepinephrine. |
2006-02-23 |
2023-08-12 |
Not clear |
| Kyoji Morita, Hideki Arimochi, Song He. Serotonergic 5-HT2A receptor stimulation induces steroid 5alpha-reductase gene expression in rat C6 glioma cells via transcription factor Egr-1. Brain research. Molecular brain research. vol 139. issue 2. 2006-01-17. PMID:15936112. |
selective serotonin reuptake inhibitors (ssris) are widely used for the treatment of depressive mood disorders and well known to inhibit the reuptake of neurotransmitter serotonin into nerve terminals. |
2006-01-17 |
2023-08-12 |
rat |
| Ellen A Walker, Stephen J Kohut, Richard W Hass, Edward K Brown, Anupama Prabandham, Timothy Lefeve. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology. vol 49. issue 8. 2006-01-17. PMID:16165167. |
serotonin(2c) (5-ht(2c)) receptors have been implicated to treat mood disorders such as depression and anxiety. |
2006-01-17 |
2023-08-12 |
mouse |
| Byung-Hwan Lee, Sang-Min Jeong, Sang-Min Jung, Jun-Ho Lee, Jong-Hoon Kim, In-Soo Yoon, Joon-Hee Lee, Sun-Hye Choi, Sang-Mok Lee, Choon-Gon Chang, Hyung-Chun Kim, YeSun Han, Hyun-Dong Paik, Yangmee Kim, Seung-Yeol Na. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Molecules and cells. vol 20. issue 1. 2006-01-06. PMID:16258243. |
in the present study, we investigated its effect on mouse 5-hydroxytryptamine type 3 (5-ht3a) receptor channel activity, which is involved in pain transmission, analgesia, vomiting, and mood disorders. |
2006-01-06 |
2023-08-12 |
mouse |
| T R Macedo, J Relvas, Fontes Ribeiro CA, F Pacheco, M T Morgadinho, C M Pinto, P C Gomes, M Ventura, V Henriques, S V Nunes, G R Ruis, C Ramalheira, I Boto, L L Val. Plasma catecholamines during an ultrarapid heroin detoxification. Annals of the New York Academy of Sciences. vol 914. 2006-01-04. PMID:11085330. |
moreover, 5-ht has been related to mood disorders. |
2006-01-04 |
2023-08-12 |
Not clear |
| Ivanor Meira-Lima, Leandro Michelon, Quirino Cordeiro, Hyong Jin Cho, Homero Vallad. Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder. Journal of molecular neuroscience : MN. vol 27. issue 2. 2005-12-06. PMID:16186633. |
the human serotonin transporter gene (5-htt) is a candidate for the pathogenesis of mood disorders, including bipolar disorder (bpd). |
2005-12-06 |
2023-08-12 |
human |
| Sevilla D Detera-Wadleigh, Francis J McMaho. Genetic association studies in mood disorders: issues and promise. International review of psychiatry (Abingdon, England). vol 16. issue 4. 2005-11-08. PMID:16194763. |
as yet, there is no widely-accepted genetic association finding in mood disorders, but functional candidate genes, such as the serotonin transporter, and positional candidates, such as g72/g30 on chromosome 13q, are beginning to be identified in several studies. |
2005-11-08 |
2023-08-12 |
Not clear |
| Malin Eberhard-Gran, Anne Eskild, Stein Opjordsmoe. Treating mood disorders during pregnancy: safety considerations. Drug safety. vol 28. issue 8. 2005-10-31. PMID:16048355. |
this paper presents an updated review of available studies on the treatment of mood disorders and present knowledge on teratogenicity, neonatal effects and long-term neurobehavioural effects for the different psychotropic drugs, including treatment with selective serotonin reuptake inhibitors (ssris), tricyclic antidepressants (tcas), other antidepressants, benzodiazepines, lithium, carbamazepine/valproic acid, lamotrigine and novel antipsychotics. |
2005-10-31 |
2023-08-12 |
Not clear |
| Gabriella Gobb. Serotonin firing activity as a marker for mood disorders: lessons from knockout mice. International review of neurobiology. vol 65. 2005-10-12. PMID:16140059. |
serotonin firing activity as a marker for mood disorders: lessons from knockout mice. |
2005-10-12 |
2023-08-12 |
mouse |
| Judith Feld, Uriel Halbreich, Sandhya Karku. The association of perimenopausal mood disorders with other reproductive-related disorders. CNS spectrums. vol 10. issue 6. 2005-10-11. PMID:15908900. |
reproductive-related mood disorders also are subject to an improvement in symptoms in response to treatment with selective serotonin reuptake inhibitors. |
2005-10-11 |
2023-08-12 |
human |
| Quiroz Danilo, Sergio Gloger, Sergio Valdivieso, José Ivelic, Carlos Fardell. [Mood disorders, psychopharmacology and thyroid hormones]. Revista medica de Chile. vol 132. issue 11. 2005-09-15. PMID:15693206. |
thyroid hormones exert their action in the central nervous system through a variety of mechanisms: modulation of gene expression of several groups of proteins, some of them with known physiopathological implications in mood disorders and the influence over serotonin and noradrenergic neurotransmission, known to be one of the modes of action of antidepressants. |
2005-09-15 |
2023-08-12 |
Not clear |
| Alessandro Serretti, Laura Mandelli, Cristina Lorenzi, Enrico Smerald. Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects. Psychiatry research. vol 134. issue 2. 2005-09-01. PMID:15840420. |
social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects. |
2005-09-01 |
2023-08-12 |
human |
| Alessandro Serretti, Laura Mandelli, Cristina Lorenzi, Enrico Smerald. Social adjustment could be associated with the serotonin transporter gene in remitted patients with mood disorders and healthy subjects. Psychiatry research. vol 134. issue 2. 2005-09-01. PMID:15840420. |
we investigated the serotonin transporter gene (5-httlpr) in the functioning of euthymic patients with mood disorders (n=285) and healthy controls (n=94). |
2005-09-01 |
2023-08-12 |
human |
| Patrick Osei-Owusu, Amy James, James Crane, Karie E Scrogi. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. The Journal of pharmacology and experimental therapeutics. vol 313. issue 3. 2005-07-14. PMID:15743927. |
neuroendocrine responses to administration of serotonin releasing agents or 5-hydroxytryptamine (5-ht) 1a receptor agonists have been used as an index of serotonin receptor function in patients with depression and other mood disorders. |
2005-07-14 |
2023-08-12 |
rat |
| Marie-José Bélanger, Norman R Simpson, Theodore Wang, Ronald L Van Heertum, J John Mann, Ramin V Parse. Biodistribution and radiation dosimetry of [11C]DASB in baboons. Nuclear medicine and biology. vol 31. issue 8. 2005-07-05. PMID:15607492. |
the serotonin transporter has been implicated in a variety of conditions including mood disorders and suicidal behavior. |
2005-07-05 |
2023-08-12 |
human |
| Janusz K Rybakowski, Aleksandra Suwalska, Piotr M Czerski, Monika Dmitrzak-Weglarz, Anna Leszczynska-Rodziewicz, Joanna Hause. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacological reports : PR. vol 57. issue 1. 2005-06-21. PMID:15849387. |
serotonin transporter promoter length polymorphism (5-httlpr) has been implicated in the pathogenesis of mood disorders and in the therapeutic response to serotonergic drugs. |
2005-06-21 |
2023-08-12 |
Not clear |
| Richard McQuade, Mel M Leitch, Sarah E Gartside, Allan H Youn. Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain. Journal of psychopharmacology (Oxford, England). vol 18. issue 4. 2005-04-12. PMID:15582915. |
dysfunction of both 5-ht(1a) receptor mediated neurotransmission and the glucocorticoid receptor is associated with mood disorders, and preclinical studies suggest that lithium treatment can modulate these receptor subtypes. |
2005-04-12 |
2023-08-12 |
rat |
| Chi-Un Pae, Jung-Jin Kim, Soo-Jung Lee, Chul Lee, In-Ho Paik, Chang-Uk Le. Aberration of cholesterol level in first-onset bipolar I patients. Journal of affective disorders. vol 83. issue 1. 2005-03-15. PMID:15546649. |
cholesterol interacts with serotonin and it has been found to be associated with some clinical symptoms of mood disorders. |
2005-03-15 |
2023-08-12 |
Not clear |